HK Stock Market Move | Joinn Laboratories (06127) increased by over 4% with a net profit attributable to the parent company of 80.7061 million yuan in the first three quarters.

date
15:00 31/10/2025
avatar
GMT Eight
Bright New Medicine (06127) surged over 4%, as of the time of writing, up 4.34% to HK$21.66, with a turnover of HK$209 million.
Joinn Laboratories (06127) rose more than 4%, as of the time of publication, it was up 4.34% to HKD 21.66, with a turnover of HKD 2.09 billion. In terms of news, Joinn Laboratories announced that in the first three quarters of 2025, the group achieved operating income of RMB 985 million, a decrease of 26.23% year-on-year; net profit attributable to shareholders was RMB 80.7061 million, compared to a loss of RMB 70.3071 million in the same period last year. The announcement mentioned that due to various factors, the company has accumulated new signed orders of approximately RMB 1.64 billion in the first three quarters, and as of the end of this reporting period, the company's overall order backlog is approximately RMB 2.5 billion. So far for the first three quarters of this year, the joinn labortories have been able to generate a revenue of 9.85 Billion Yuan which is 26.23 % less compared to last year. The net profit of the company has also reflected an increasing trend, with the current net profit as 8 billion 706 million Yuan, which is a sharp contrast compared to last year's loss of 7 billion 30 million Yuan.